Navigation Links
Colby Pharmaceutical Company Announces Dramatic Results: Novel Technology Increases Influenza Vaccine Protection for Elderly Rhesus Monkeys
Date:11/5/2013

nts clearly demonstrate that the JVRS-100 adjuvanted flu vaccine is ready to go to the next level in clinical development.” He added, “Colby is seeking vaccine partners for the next phase of development of our JVRS-100 vaccine portfolio.”

“Improving the effectiveness of influenza vaccination for the elderly is a critical public health need,” stated Dr. Robert Malone, M.D., M.S., an internationally recognized vaccine expert. He added that, “Dr. Chris Miller and his colleagues at the Center for Comparative Medicine are among the best non-human primate immunologists and vaccine researchers in the world, and I have confidence in their research findings. In these collaborative studies, Colby has now advanced the CLDC adjuvant to the point that JVRS-100 merits expedited human clinical testing when formulated with pandemic influenza and other respiratory virus vaccine candidates.”

Colby is also clinically developing JVRS-100 CLDC as a stand-alone immune activator drug for cancer patients and, in addition, as an immune activating adjuvant, especially in combination with the influenza vaccine for a seasonal human flu and a pre-pandemic H5N1 vaccine. Colby has developed both therapeutic and preventative applications for JVRS-100, primarily for those medical situations where generation of a robust and durable immune response would be challenging, as in elderly or other immune-compromised individuals.

David Zarling will be discussing Colby Pharmaceutical Company at the East Meets West CEO Conference at the Four Seasons Hotel, San Francisco, CA on January 12, 2014 at 1PM PDT.

About Colby

Colby is developing and selling drug candidates from its pipeline of targeted biologic and small molecules. This includes the JVRS-100 CLDC (Cationic Lipid DNA Complex) biopharmaceutical and small molecule targeted drugs that affect immunity. In 2011, Colby focused its biologics product development on JVRS-100 CLDC as a stand-alone therapy in cance
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
3. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
4. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
5. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
7. The respective roles of the public and private sectors in pharmaceutical innovation
8. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
9. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
10. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 This webinar will focus ... and clinical safety assessment in biosimilars. , Regulatory ... path for biosimilar drug development, however the complex ... with regards to quality, safety and efficacy extremely ... drug development and registration, development strategies differ significantly ...
(Date:1/15/2014)... DTS Language Services, Inc . is pleased ... for Life Science organizations who need document translations. ... subject matter of their documents in advance with a ... help reduce time-to-delivery of translations, often a critical factor ... of error. , “All translations are inherently time-sensitive by ...
(Date:1/14/2014)... 14, 2014 Date: Friday, April 11, ... Location: Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... only national nonprofit organization solely dedicated to finding a ... life for those affected worldwide, will host its annual ... Club in Warrington, Pa. , Each year, the ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Borough ... Challenge. , ... (Vocus) March 12, 2010 -- Borough of Manhattan Community College (BMCC) science major ... Science Challenge—as well as $5,000 as an overall Grand Prizewinner., , , , ,Thompson--the contest,s ...
... ... , ... ... SEATTLE, WA , March 12 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) today announced that it will restate its ...
... , THOUSAND OAKS, Calif. , March 11 Bone Biologics, Inc. announced today that it has received a US Patent Office Notice ... of the NELL 1 (UCB-1) protein by several delivery agents. , ... , ... ...
Cached Biology Technology:BMCC Student—the Only Community College Winner—Lands Grand Prize in Nobel Science Challenge 2Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 2Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 3Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 4Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 5Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 6Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 7Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 8Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 9Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 10Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 2Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 3
(Date:4/15/2014)... for nearly all life on Earth, yet many aspects ... is known about how it is regulated in response ... not know the full list of the parts of ... , , A type of single-cell green algae called ... photosynthesis research. Despite its importance in the research world, ...
(Date:4/15/2014)... early as 2020 how high sea levels will rise ... researchers including Florida International University scientist Rene Price. , ... (NSF) Florida Coastal Everglades Long-Term Ecological Research (LTER) site, ... from coral reefs to deserts, mountains to salt marshes ... rise is one of the most certain consequences of ...
(Date:4/15/2014)... previously shown that a genetic pre-disposition to be more ... study, Frank Booth, a professor in the MU College ... the genetic pre-disposition for high levels of exercise motivation ... For his study, Booth selectively bred rats that exhibited ... then put the rats in cages with running wheels ...
Breaking Biology News(10 mins):Long-term predictions for Miami sea level rise could be available relatively soon 2Genetic pre-disposition toward exercise and mental development may be linked 2
... between a gene involved in vitamin D metabolism and skin ... CANCER , a peer-reviewed journal of the American Cancer Society, ... vitamin D-related gene, called BsmI, may be at an increased ... D in the body has significant protective effects against the ...
... of Minnesota College of Veterinary Medicine have identified a gene ... exercise-induced collapse (EIC). After intense hunting or retrieving exercise, activities ... lose control of their hind limbs. In most cases, ... in rare cases the dogs may die. Labradors are ...
... Two professors at Cold Spring Harbor Laboratory (CSHL) have ... of proteins that enable genes to express themselves in ... Michael Q. Zhang, Ph.D. and Adrian R. Krainer, ... are exploring a phenomenon that biologists and geneticists call ...
Cached Biology News:Variant of vitamin D receptor gene linked to melanoma risk 2U of M researchers identify gene linked to common ailment in labrador retrievers 2CSHL team traces extensive networks regulating alternative RNA splicing 2CSHL team traces extensive networks regulating alternative RNA splicing 3CSHL team traces extensive networks regulating alternative RNA splicing 4
... analysis software with the DeCypher Engine accelerator cards ... can perform searches like these from your desktop: ... in under 6 days Align BAC-sized ... Use HMM analysis to compare 100,000 sequences to ...
Mouse monoclonal antibody to FMN2 - formin 2...
Rabbit polyclonal to SMARCA2 / BRM - ChIP Grade ( Abpromise for all tested applications). entrezGeneID: 6595 SwissProtID: P51531...
Mouse monoclonal [CAT-2] to Chloramphenicol Acetyltransferase...
Biology Products: